Tags

Type your tag names separated by a space and hit enter

IMAP statement on Norplant subdermal contraceptive implant system.
IPPF Med Bull. 1993 Apr; 27(2):1-3.IM

Pub Type(s)

Journal Article

Language

eng

PubMed ID

12345306

Citation

International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP. "IMAP Statement On Norplant Subdermal Contraceptive Implant System." IPPF Medical Bulletin, vol. 27, no. 2, 1993, pp. 1-3.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP. IMAP statement on Norplant subdermal contraceptive implant system. IPPF Med Bull. 1993;27(2):1-3.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP. (1993). IMAP statement on Norplant subdermal contraceptive implant system. IPPF Medical Bulletin, 27(2), 1-3.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP. IMAP Statement On Norplant Subdermal Contraceptive Implant System. IPPF Med Bull. 1993;27(2):1-3. PubMed PMID: 12345306.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - IMAP statement on Norplant subdermal contraceptive implant system. A1 - ,, PY - 1993/4/1/pubmed PY - 2002/10/9/medline PY - 1993/4/1/entrez KW - Biology KW - Clinic Activities KW - Contraception KW - Contraception Continuation KW - Contraceptive Agents, Female--beneficial effects KW - Contraceptive Agents, Female--contraindications KW - Contraceptive Agents, Female--side effects KW - Contraceptive Agents, Progestin--beneficial effects KW - Contraceptive Agents, Progestin--contraindications KW - Contraceptive Agents, Progestin--side effects KW - Contraceptive Agents--beneficial effects KW - Contraceptive Agents--contraindications KW - Contraceptive Agents--side effects KW - Contraceptive Effectiveness KW - Contraceptive Implants KW - Contraceptive Methods KW - Contraceptive Mode Of Action KW - Contraceptive Usage KW - Counseling KW - Family Planning KW - Insertion KW - Levonorgestrel--beneficial effects KW - Levonorgestrel--contraindications KW - Levonorgestrel--side effects KW - Metabolic Effects KW - Method Acceptability KW - Physiology KW - Program Activities KW - Programs KW - Reversibility KW - Treatment SP - 1 EP - 3 JF - IPPF medical bulletin JO - IPPF Med Bull VL - 27 IS - 2 SN - 0019-0357 UR - https://www.unboundmedicine.com/medline/citation/12345306/IMAP_statement_on_Norplant_subdermal_contraceptive_implant_system_ L2 - https://medlineplus.gov/birthcontrol.html DB - PRIME DP - Unbound Medicine ER -